1. Ferreira AM, Westers H, Albergaria A, Seruca R, Hofstra RM

Estrogen, MSI and Lynch syndrome-associated tumours Biochimica et Biophysica acta-Reviews on Cancer 0: 0, 2009.  [Review] 

 PMID: 19559756.

 

2. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R

Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et Biophysica acta-Reviews on Cancer 1826: 297-311, 2012.  [Review] 

 doi: 10.1016/j.bbcan.2012.05.002 PMID: 22613680.

 

3. Albergaria A, Ribeiro AS, Pinho S, Milanezi F, Carneiro V, Sousa B, Sousa S, Oliveira C, Machado JC, Seruca R, Paredes J, Schmitt F

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Human molecular genetics 19: 2554-66, 2010.  [Article] 

 doi: 10.1093/hmg/ddq134 PMID: 20385540.

 

4. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J

P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem cells (Dayton, Ohio) 30: 854-64, 2012.  [Article] 

 doi: 10.1002/stem.1075 PMID: 22389315.

 

5. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402, 2010.  [Article] 

 doi: 10.1038/onc.2009.338 PMID: 19901964.

 

6. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology 229: 705-18, 2013.  [Article] 

 doi: 10.1002/path.4143 PMID: 23180380.

 

7. Goto T, Takano M, Albergaria A, Briese J, Pomeranz KM, Cloke B, Fusi L, Feroze-Zaidi F, Maywald N, Sajin M, Dina RE, Ishihara O, Takeda S, Lam EW, Bamberger AM, Ghaem-Maghami S, Brosens JJ

Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Oncogene 27: 9-19, 2008.  [Article] 

 doi: 10.1038/sj.onc.1210626 PMID: 17599040.

 

8. Vieira AF, Ribeiro AS, Dionísio MR, Sousa B, Nobre AR, Albergaria A, Santiago-Gómez A, Mendes N, Gerhard R, Schmitt F, Clarke RB, Paredes J

P-cadherin signals through the laminin receptor a6ß4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget 5: 679-92, 2014.  [Article] 

 PMID: 24553076.

 

9. Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical cancer research : an official journal of the American Association for Cancer Research 11: 5869-77, 2005.  [Article] 

 doi: 10.1158/1078-0432.CCR-05-0059 PMID: 16115928.

 

10. Ribeiro AS, Sousa B, Carreto L, Mendes N, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin promotes cancer cell invasion by interference with E-cadherin suppressor function The FASEB Journal  1, 2011.  [] 

.

 

11. Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast cancer research : BCR 11: 3, 2009.  [Article] 

 PMID: 19549328.

 

12. Krol J, Francis RE, Albergaria A, Sunters A, Polychronis A, Coombes RC, Lam EW

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells. Molecular cancer therapeutics 6: 3169-79, 2007.  [Article] 

 doi: 10.1158/1535-7163.MCT-07-0507 PMID: 18089711.

 

13. Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC

P-cadherin expression in breast cancer: a review. Breast cancer research : BCR 9: 214, 2007.  [Review] 

 doi: 10.1186/bcr1774 PMID: 18001487.

 

14. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F

Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56: 860-7, 2010.  [Article] 

 doi: 10.1111/j.1365-2559.2010.03560.x PMID: 20636790.

 

15. Albergaria A, Resende C, Nobre AR, Ribeiro AS, Sousa B, Machado JC, Seruca R, Paredes J, Schmitt F

CCAAT/enhancer binding protein ß (C/EBPß) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells. PloS one 8: e55749, 2013.  [Article] 

 doi: 10.1371/journal.pone.0055749 PMID: 23405208.

 

16. Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC cancer 14: 734, 2014.  [Article] 

 doi: 10.1186/1471-2407-14-734 PMID: 25269858.

 

17. Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool? BMC cancer 11: 299, 2011.  [Article] 

 doi: 10.1186/1471-2407-11-299 PMID: 21762477.

 

18. Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F

Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Human pathology 42: 1438-46, 2011.  [Article] 

 doi: 10.1016/j.humpath.2010.08.024 PMID: 21450330.

 

19. Albergaria A, Ribeiro A S, Vieira AF, Sousa B, Nobre AR, Seruca R, Schmitt F, Paredes J

P-cadherin role in normal breast development and cancer. International Journal Dev Biology  811-822, 2011.  [Article] 

 doi: 10.1387/ijdb.113382aa.

 

20. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC

p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. Journal of clinical pathology 55: 936-9, 2002.  [Article] 

 PMID: 12461063.

 

21. Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histology and histopathology 25: 963-74, 2010.  [Article] 

 PMID: 20552547.

 

22. Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo AF, Cameselle-Teijeiro JF, Paredes J, Schmitt F

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast (Edinburgh, Scotland) 21: 354-60, 2012.  [Article] 

 doi: 10.1016/j.breast.2012.03.001 PMID: 22464177.

 

23. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F

GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histology and histopathology 26: 1279-86, 2011.  [Article] 

 PMID: 21870331.

 

24. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC

Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer 99: 172-9, 2003.  [Article] 

 doi: 10.1002/cncr.11061 PMID: 12811858.

 

25. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC

Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Archiv : an international journal of pathology 441: 551-8, 2002.  [Article] 

 doi: 10.1007/s00428-002-0710-1 PMID: 12461611.

 

26. Nobre AR, Albergaria A, Schmitt F

p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63. Acta cytologica 57: 1-8, 2013.  [Review] 

 doi: 10.1159/000345245 PMID: 23221041.

 

27. Gerhard R, Carvalho A, Carneiro V, Bento RS, Uemura G, Gomes M, Albergaria A, Schmitt F

Clinicopathological significance of ERCC1 expression in breast cancer. Pathology, research and practice 209: 331-6, 2013.  [Article] 

 doi: 10.1016/j.prp.2013.02.009 PMID: 23702380.

 

28. Gama A, Paredes J, Albergaria A, Gartner F, Schmitt F

P-cadherin expression in canine mammary tissues. Journal of comparative pathology 130: 13-20, 2004.  [Article] 

 PMID: 14693120.

 

29. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC

p63 expression in normal skin and usual cutaneous carcinomas. Journal of cutaneous pathology 29: 517-23, 2002.  [Article] 

 PMID: 12358808.

 

30. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I, Schmitt FC

Naked nuclei revisited: p63 Immunoexpression. Diagnostic cytopathology 27: 135-8, 2002.  [Article] 

 doi: 10.1002/dc.10164 PMID: 12203858.

 

31. Longatto Filho A, Albergaria A, Paredes J, Moreira MA, Milanezi F, Schmitt FC

P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology. Cytopathology : official journal of the British Society for Clinical Cytology 16: 88-93, 2005.  [Article] 

 doi: 10.1111/j.1365-2303.2004.00226.x PMID: 15787651.

 

32. Paredes J, Albergaria A, Carvalho S, Schmitt F

"Basal-like" breast cancer carcinomas: Identification by P-cadherin, p63, EGFR and basal cytokeratins expression. Applied Cancer Research 26: 41-55, 2006.  [] 

.